Drug combinations‐uses, dangers, and fallacies

E-ISSN： 1532-6535|9-9236|6part1|673-676

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.9-9236, Iss.6part1, 1964-11, pp. : 673-676

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug combinations in India

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 21, Iss. 5, 1996-10 ,pp. : 283-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiblastic Drug Combinations with Ifosfamide: An Update

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 21-30

Karger

Access to resources Recommend Favorite

Drug repurposing screens and synergistic drug‐combinations for infectious diseases

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 2, 2018-01 ,pp. : 181-191

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aflibercept ophthalmic solution: drug development and clinical uses

By Stewart Michael W

Clinical Investigation, Vol. 3, Iss. 11, 2013-11 ,pp. : 1045-1056

Future Science

Access to resources Recommend Favorite

Considerations on clinical trials of leprosy treatment: need of novel drug combinations

By Illarramendi Ximena de Oliveira Maria Leide Wand del Rey Sales Anna Maria da Costa Nery José Augusto Sarno Euzenir Nunes

Clinical Investigation, Vol. 3, Iss. 7, 2013-07 ,pp. : 617-635

Future Science

Access to resources Recommend Favorite